Enzo Biochem Inc - ESG Rating & Company Profile powered by AI
Check the bottom of this page for potential risks for Enzo Biochem Inc based on industry, location and size. This ESG rating covers 17 UN SDGs including: 'Clean Water & Sanitation', 'Decent Work & Economic Growth' and 'Life below Water'. This webpage contains a Q&A table on Enzo Biochem Inc.
Enzo Biochem Inc in the Healthcare Facilities & Services industry gained a UN SDG ESG Transparency Score of 4.6; made up of an environmental score of 2.7, social score of 3.2 and governance score of 8.0.
4.6
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Cambian Group Ltd | 8.0 | High |
1 | Cedar Co Ltd | 8.0 | High |
163 | Prodia Widyahusada Tbk PT | 4.7 | High |
163 | Shifa International Hospitals Ltd | 4.7 | High |
166 | Enzo Biochem Inc | 4.6 | High |
166 | Aidigong Maternal & Child Health Ltd | 4.6 | High |
168 | Caretech Holdings PLC | 4.5 | High |
... | ... | ... | |
362 | eWellness Healthcare Corp | 0.0 | Low |
362 | iKang Healthcare Group Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Enzo Biochem Inc have an accelerator or VC vehicle to help deliver innovation?
Does Enzo Biochem Inc disclose current and historical energy intensity?
Does Enzo Biochem Inc report the average age of the workforce?
Does Enzo Biochem Inc reference operational or capital allocation in relation to climate change?
Does Enzo Biochem Inc disclose its ethnicity pay gap?
Does Enzo Biochem Inc disclose cybersecurity risks?
Does Enzo Biochem Inc offer flexible work?
Does Enzo Biochem Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Enzo Biochem Inc disclose the number of employees in R&D functions?
Does Enzo Biochem Inc conduct supply chain audits?
Does Enzo Biochem Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Enzo Biochem Inc conduct 360 degree staff reviews?
Does Enzo Biochem Inc disclose the individual responsible for D&I?
Does Enzo Biochem Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Enzo Biochem Inc disclose current and / or historical scope 2 emissions?
Does Enzo Biochem Inc disclose water use targets?
Does Enzo Biochem Inc have careers partnerships with academic institutions?
Did Enzo Biochem Inc have a product recall in the last two years?
Does Enzo Biochem Inc disclose incidents of discrimination?
Does Enzo Biochem Inc allow for Work Councils/Collective Agreements to be formed?
Has Enzo Biochem Inc issued a profit warning in the past 24 months?
Does Enzo Biochem Inc disclose parental leave metrics?
Does Enzo Biochem Inc disclose climate scenario or pathway analysis?
Does Enzo Biochem Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Enzo Biochem Inc disclose the pay ratio of women to men?
Does Enzo Biochem Inc support suppliers with sustainability related research and development?
Does Enzo Biochem Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Enzo Biochem Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Enzo Biochem Inc involved in embryonic stem cell research?
Does Enzo Biochem Inc disclose GHG and Air Emissions intensity?
Does Enzo Biochem Inc disclose its waste policy?
Does Enzo Biochem Inc report according to TCFD requirements?
Does Enzo Biochem Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Enzo Biochem Inc disclose energy use targets?
Does Enzo Biochem Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Enzo Biochem Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Enzo Biochem Inc
These potential risks are based on the size, segment and geographies of the company.
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing "STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in New York, New York.